Catalpol , Analysis of standard products, ≥97%(HPLC) , 2415-24-9
                            Synonym(s):
(1aS,1bS,2S,5aR,6S,6aS)-1a,1b,2,5a,6,6a-Hexahydro-6-hydroxy-1a-(hydroxymethyl)oxireno[4,5]cyclopenta[1,2-c]pyran-2-yl-β-D -glucopyranoside;Catalpinoside;De(p-hydroxybenzoyl)catalposide
                            
                        
                CAS NO.:2415-24-9
Empirical Formula: C15H22O10
Molecular Weight: 362.33
MDL number: MFCD11111524
EINECS: 219-324-0
| Pack Size | Price | Stock | Quantity | 
| 20MG | RMB234.40 | In Stock | 
                                                 | 
                                        
| others | Enquire | 
PRODUCT Properties
| Melting point: | 203-205°C | 
                                    
| Boiling point: | 675.6±55.0 °C(Predicted) | 
                                    
| Density | 1.72±0.1 g/cm3(Predicted) | 
                                    
| storage temp. | Inert atmosphere,Store in freezer, under -20°C | 
                                    
| solubility | DMSO (Slightly), Ethanol (Slightly, Sonicated), Methanol (Slightly) | 
                                    
| form | Solid | 
                                    
| pka | 12.79±0.70(Predicted) | 
                                    
| color | White to Off-White | 
                                    
| InChI | InChI=1/C15H22O10/c16-3-6-9(19)10(20)11(21)14(23-6)24-13-7-5(1-2-22-13)8(18)12-15(7,4-17)25-12/h1-2,5-14,16-21H,3-4H2/t5-,6-,7-,8+,9-,10+,11-,12+,13+,14+,15-/s3 | 
                                    
| InChIKey | LHDWRKICQLTVDL-CLLMHHLUSA-N | 
                                    
| SMILES | C([C@]12O[C@H]1[C@@H](O)[C@]1([H])C=CO[C@@H](O[C@@]3([H])[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)[C@]21[H])O |&1:1,3,4,6,11,13,15,16,18,20,25,r| | 
                                    
| LogP | -4.609 (est) | 
                                    
Description and Uses
Catalpol is an iridoid glycoside that has been isolated from R. glutinosa and has diverse biological activities, including anti-apoptotic, pro-angiogenic, and radioprotective properties. It protects against mitochondrial pathway-dependent apoptosis in PC12 rat adrenal pheochromocytoma cells and H9c2 rat embryonic ventricular myocardial cells when used at a concentration of 10 μM. Catalpol pretreatment reduces apoptosis and improves viability in AHH-1 human lymphocyte cells exposed to ionizing radiation and reduces intestinal damage induced by radiation in mice when used at concentrations and doses ranging from of 25 to 100 μg/ml and 25 to 100 mg/kg, respectively. In a rat model of stroke, catalpol (5 mg/kg, i.p.) increases the expression of erythropoietin and VEGF and improves angiogenesis in the brain.
Catapol is an iridoid glucoside that has been shown to alleviate neuropathic pain.
Safety
| Symbol(GHS) | ![]() GHS07  | 
                                    
| Signal word | Warning | 
| Hazard statements | H315-H319-H335 | 
| Precautionary statements | P261-P264-P271-P280-P302+P352-P305+P351+P338 | 
| Hazard Codes | Xi | 
| Risk Statements | 36/37/38 | 
| Safety Statements | 26-36 | 
| WGK Germany | 3 | 
| RTECS | LZ5776816 | 
| HS Code | 29389090 | 
| Toxicity | mouse,LD,intravenous,> 2500mg/kg (2500mg/kg),Nippon Yakurigaku Zasshi. Japanese Journal of Pharmacology. Vol. 64, Pg. 93, 1968. | 





